AGN-223575

· Allergan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-223575, covering 2016-04-12 to 2016-04-12. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects [Phase 1]